Skip to main content

Table 4 Risk for cardiovascular outcomes or cardiovascular mortality

From: Prognostic value of non-specific ST-T changes and left ventricular hypertrophy electrocardiographic criteria in hypertensive patients: 16-year follow-up results from the MINACOR cohort

  HR [95% CI] adjusted for gender, age, SBP, DM2 incidence, major or minor ECG abnormalities and smoking P -value Crude HR [95% CI] P -value
Major or minor ECG abnormalities 0.97 [0.49 -1.90] 0.923 1.33 [0.69 - 2.54] 0.387
Gender (Male) 1.08 [0.59 - 1.96] 0.804 1.18 [0.73 - 1.90] 0.491
Age 1.07 [1.03 - 1.12] 0.002 1.07 [1.02 - 1.11] 0.003
SBP 1.01 [1.00 - 1.03] 0.053 1.02 [1.00 - 1.03] 0.022
DM incidence 1.97 [1.21 - 3.20] 0.006 2.08 [1.30 - 3.30] 0.003
Smoking 1.98 [1.06 - 3.70] 0.032 1.71 [1.05 - 2.80] 0.033
  1. LVH, Left Ventricular Hypertrophy; HR: Hazard Ratio; SBP, Systolic Blood Pressure; DM: Type 2 Diabetis; CI, confidence interval.
  2. Hazard ratios were estimated using proportional hazards (Cox) regression modeling with major or minor electrocardiographic (ECG) abnormalities.